BioPlant, a dental bone grafting material. BioPlant has been assigned the product code LYC (Bone Grafting Material, Synthetic) by the FDA and is classified as a Class II Medical Device. BioPlant is a Class II Medical Device. The Device Listing Number is 0007254. BioPlant is a synthetic, multipurpose bone-grafting material intended to be used in dental applications to maintain and restore the bony alveolar ridge in post-extraction tooth-root sockets or after oral surgery, ridge preservation, ridge augmentation, augmentations in the maxillary sinus, repair of periodontal defects and bone voids associated with dental implant placement.
Publicado el 28 de noviembre de 2012 · Inicio del retiro: 25 de octubre de 2012
Resumen
FDA registra el retiro Z-0401-2013 de dispositivos médicos de Clase II, publicado el 28 de noviembre de 2012 e iniciado el 25 de octubre de 2012. Empresa responsable: Kerr Corporation; Estado: Finalizado; Cantidad reportada: 22,410 units; Lote: The BioPlant part numbers and lot numbers affected by this recall are as follows: Product Description Part Numbers Lot Numbers BioPlant Curved Syringe, 0.125g 216110 All Production BioPlant Curved Syringe, 0.25g 216112 BioPlant Curved Svrinoe, 0.50<1 216114 Lots Within Shelf-Life BioPlant Curved Svrinoe, 0.250 216132 20k BioPlant Intro Pack 216112S. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.
Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
The firm initiated the recall becaue disturbing the BioPlant product soon after it is placed may halt or delay the ossification process.
Qué hacer
Voluntary: Firm initiated · Letter
Recibe un correo cuando FDA publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Fabricante
- Kerr Corporation
- Distribuidor
- Worldwide Distribution - USA (nationwide) Canada, Europe, Australia and ROW consignees .
- Lote
- The BioPlant part numbers and lot numbers affected by this recall are as follows: Product Description Part Numbers Lot Numbers BioPlant Curved Syringe, 0.125g 216110 All Production BioPlant Curved Syringe, 0.25g 216112 BioPlant Curved Svrinoe, 0.50<1 216114 Lots Within Shelf-Life BioPlant Curved Svrinoe, 0.250 216132 20k BioPlant Intro Pack 216112S
- Clasificación de riesgo
- Class II
- Área (FDA)
- device
- País
- United States
Retiros relacionados
- FDATytin Regular Set, Double Spill, 50 Capsules, Part Number 29948, Lot Number 3-1294. The intended use of this25 de junio de 2014
- FDAFreedom Cordless LED Light System. Freedom System, Standard Length, Part Number 910863-1, Serial Numbers28 de noviembre de 2012
- FDAThe brand name of the device is Laser Loupes, a dentalloupe with laser eye protection. Laser Loupes have been28 de noviembre de 2012
- FDA00780304001 MIS 12/14 Slotted Femoral Head Provisional -3.5X36 00780304002 MIS 12/14 Slotted Femoral Head28 de noviembre de 2012
- FDA00780303601 MIS 12/14 Slotted Femoral Head Provisional -3.5X36 00780303602 MIS 12/14 Slotted Femoral Head28 de noviembre de 2012
- FDAThe brand name of the device is AlgiNot, a dental impression material. Product Part Numbers AlgiNot Intra Kit14 de noviembre de 2012
Preguntas sobre este retiro
¿BioPlant, a dental bone grafting material. BioPlant has been assigned the product code LYC (Bone Grafting Material, Synthetic) by the FDA and is classified as a Class II Medical Device. BioPlant is a Class II Medical Device. The Device Listing Number is 0007254. BioPlant is a synthetic, multipurpose bone-grafting material intended to be used in dental applications to maintain and restore the bony alveolar ridge in post-extraction tooth-root sockets or after oral surgery, ridge preservation, ridge augmentation, augmentations in the maxillary sinus, repair of periodontal defects and bone voids associated with dental implant placement. fue retirado del mercado?
Sí. FDA publicó el retiro Z-0401-2013 el 28 de noviembre de 2012. Peligro reportado: The firm initiated the recall becaue disturbing the BioPlant product soon after it is placed may halt or delay the ossification process.
¿Qué debo hacer si tengo este producto?
Voluntary: Firm initiated · Letter